Molecular Medicine and Gene Therapy

Faculty of Medicine | Lund University

Menu

Molecular Medicine and Gene Therapy

bmc view banner

The Division of Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. Established as a joint venture between the Medical Faculty at Lund University and the Hematology Clinic at Lund University Hospital, our mission is to translate basic science to clinical applications.

Our research focuses on hematopoiesis, the continuous and dynamic process of blood cell formation. The laboratory consists of eight closely collaborating research groups that all share a common interest in investigating the properties of blood stem cells to eventually understand and treat hematological disorders.

Five of our researchers belong to the Hemato-Linné Excellence Linnaeus Research Environment funded by The Swedish Research Council and Lund University. Several of the groups are engaged in StemTherapy, a Strategic Research Area for Stem Cells and Regenerative Medicine that is also supported by The Swedish Research Council.

News

niels bjarne woods

Stem Cell Talks by Niels-Bjarne Woods "De novo generation of hematopoietic stem cells: What’s the problem?" 

When? Wednesday, December 14, 2016 at 14:45 

Where? Segerfalk Lecture Hall, BMC A10 

Welcome!

els mansell

Please welcome Els Mansell, who joins us from the University of Bristol, UK. Els will be part of the Wallenberg team under the supervision of Professor Tariq Enver, who holds a visiting professorship at our Division in addition to directing the Cancer Institute at UCL, London, UK. The aim of the Wallenberg project is to understand the rules for how the stem cell compartment is organized to sustain regeneration throughout life.

Welcome to our Division Els!

justyna rak
Justyna Rak

Congratulations to Justyna Rak and co-authors, whose article "Cytohesin 1 regulates homing and engraftment of human hematopoietic stem- and progenitor cells" has been published in Blood. Using an RNA-interference screen targeted to human hematopoietic stem and progenitor cells (HSPCs), Justyna, a former postdoc in the Larsson group, identified Cytohesin 1 as a novel mediator of adhesion and engraftment in human HSPCs. 

Congratulations to all authors!

johan flygare and sandra capellera
Johan Flygare and Sandra Capellera

Sandra Capellera-Garcia et al.'s article entitled “Defining the Minimal Factors Required for Erythropoiesis through Direct Lineage Conversion”, published in Cell Reports this June, has been selected the Lund Medical Faculty Monthly (LMFM) article of the month by the LMFM editorial group. The main goal of the LMFM is to attract anyone who has an interest in the research at the Faculty of Medicine, Lund University, including local, national, and international researchers and health professionals as well as science journalists and the general public.

Congratulations Sandra and all co-authors!

Listen to Johan Flygare, Associate Professor at the Division of Molecular Medicine and Gene Therapy, and Sandra Capellera Garcia, PhD student in the Flygare lab, speak about their research on artificial blood on the Swedish radio show "Vetandets värld" on P1 (in Swedish).

Site overview